Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Pasquini

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Defining the intensity of conditioning regimens: working definitionsAndrea Bacigalupo, Karen Ballen, Doug Rizzo, et al.
American Journal of Hematology|July 13, 2017
Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host diseaseJames H Jerkins, Mehdi Hamadani, Felicia Zook, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2019
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple MyelomaAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2017
Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia SyndromeJonathan Thompson, Ziyan Yin, Anita D'Souza, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2013
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
British Journal of Haematology|June 14, 2016
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative studyAnita D'Souza, Marcelo Pasquini, Brent Logan, et al.
Blood|December 6, 2013
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2015
Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell TransplantationTheresa Hahn, Lara E Sucheston-Campbell, Leah Preus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 22, 2018
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell TransplantChristopher Strouse, Ying Zhang, Mei-Jie Zhang, et al.
Blood Advances|June 18, 2024
Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS interventionFateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Defining the intensity of conditioning regimens: working definitionsAndrea Bacigalupo, Karen Ballen, Doug Rizzo, et al.
American Journal of Hematology|July 13, 2017
Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host diseaseJames H Jerkins, Mehdi Hamadani, Felicia Zook, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2019
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple MyelomaAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2017
Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia SyndromeJonathan Thompson, Ziyan Yin, Anita D'Souza, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2013
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
British Journal of Haematology|June 14, 2016
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative studyAnita D'Souza, Marcelo Pasquini, Brent Logan, et al.
Blood|December 6, 2013
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2015
Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell TransplantationTheresa Hahn, Lara E Sucheston-Campbell, Leah Preus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 22, 2018
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell TransplantChristopher Strouse, Ying Zhang, Mei-Jie Zhang, et al.
Blood Advances|June 18, 2024
Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS interventionFateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, et al.
Pageof 9